Treatment with Anti–Gremlin 1 Antibody Ameliorates Chronic Hypoxia/SU5416–Induced Pulmonary Arterial Hypertension in Mice-Reference-Cited by-同舟云学术

Treatment with Anti–Gremlin 1 Antibody Ameliorates Chronic Hypoxia/SU5416–Induced Pulmonary Arterial Hypertension in Mice

Published:2013-11 Issue:5 Volume:183 Page:1461-1473
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Ciuclan Loredana,Sheppard KellyAnn,Dong Liqun,Sutton Daniel,Duggan Nicholas,Hussey Martin,Simmons Jenny,Morrell Nicholas W.,Jarai Gabor,Edwards Matthew,DuBois Gerald,Thomas Matthew,Van Heeke Gino,England Karen

Funder

Novartis Foundation

National Institutes of Health

Novartis Institutes for BioMedical Research

National Institute for Health Research

Novartis

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference35 articles.

1. Formation of plexiform lesions in experimental severe pulmonary arterial hypertension;Abe;Circulation,2010

2. Cellular and molecular pathobiology of pulmonary arterial hypertension;Humbert;J Am Coll Cardiol,2004

3. Pathobiology of pulmonary hypertension;Rabinovitch;Ann Rev Pathol,2007

4. Vascular remodeling versus vasoconstriction in chronic hypoxic pulmonary hypertension: a time for reappraisal?;Stenmark;Circ Res,2005

5. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms;Stenmark;Circ Res,2006

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction;Circulation;2024-09-10

2. Targeting Soluble TGF-β Factors;JACC: Basic to Translational Science;2024-06

3. Bone morphogenic protein-4 availability in the cardiac microenvironment controls inflammation and fibrosis in autoimmune myocarditis;Nature Cardiovascular Research;2024-02-19

4. Discovery of ginisortamab, a potent and novel anti-gremlin-1 antibody in clinical development for the treatment of cancer;mAbs;2023-12-12

5. Adipokines in pulmonary hypertension: angels or demons?;Heliyon;2023-11